Molecular Dynamics Simulations of the HIV-1 Integrase Dimerization Interface: Guidelines for the Design of a Novel Class of Integrase Inhibitors

被引:11
|
作者
Sippel, Martin [1 ]
Sotriffer, Christoph A. [1 ]
机构
[1] Julius Maximilians Univ Wuerzburg, Inst Pharm & Food Chem, D-97074 Wurzburg, Germany
关键词
PROTEIN-PROTEIN INTERACTIONS; VIRUS TYPE-1 INTEGRASE; PEPTIDE INHIBITORS; AUTOMATED DOCKING; GENETIC ALGORITHM; SCORING FUNCTION; BINDING MODES; LIGAND; DISCOVERY; RALTEGRAVIR;
D O I
10.1021/ci900403s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
HIV-1 integrase (IN) is a validated target of anti-AIDS research. The classical approach of designing active-site directed ligands has largely been exploited. A promising alternative strategy to inactivate the enzyme is to prevent the formation of IN dimers. The rational design of dimerization inhibitors, however, is hampered by the lack of relevant structural data about the targeted monomeric form. Therefore, we performed molecular dynamics simulations and subsequent analyses to gain insight into the structural features of the IN catalytic-core-domain dimerization interface. As a result, the formation of a groove and a cavity along the dimerization interface of the IN monomer could be revealed. Both were shown to be suited for accommodating an inhibitory peptide. The results form a valuable basis for the design of ligands targeting the dimerization interface and, thus, of a whole new class of HIV-1 integrase inhibitors.
引用
收藏
页码:604 / 614
页数:11
相关论文
共 50 条
  • [21] Authentic HIV-1 integrase inhibitors
    Liao, Chenzhong
    Marchand, Christophe
    Burke, Terrence R., Jr.
    Pommier, Yves
    Nicklaus, Marc C.
    FUTURE MEDICINAL CHEMISTRY, 2010, 2 (07) : 1107 - 1122
  • [22] Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase
    Verschueren, WG
    Dierynck, I
    Amssoms, KIE
    Hu, LL
    Boonants, PMJG
    Pille, GME
    Daeyaert, FFD
    Hertogs, K
    Surleraux, DLNG
    Wigerinck, PBTP
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 1930 - 1940
  • [23] A Symmetric Region of the HIV-1 Integrase Dimerization Interface Is Essential for Viral Replication
    Serrao, Erik
    Thys, Wannes
    Demeulemeester, Jonas
    Al-Mawsawi, Laith Q.
    Christ, Frauke
    Debyser, Zeger
    Neamati, Nouri
    PLOS ONE, 2012, 7 (09):
  • [24] Molecular modelling and QSAR in the discovery of HIV-1 integrase inhibitors
    Almerico, Anna M.
    Tutone, Marco
    Ippolito, Mario
    Lauria, Antonino
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2007, 3 (03) : 214 - 233
  • [25] De novo design and synthesis of HIV-1 integrase inhibitors
    Makhija, MT
    Kasliwal, RT
    Kulkarni, VM
    Neamati, N
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (09) : 2317 - 2333
  • [26] Development of a fluorescence-based HIV-1 integrase DNA binding assay for identification of novel HIV-1 integrase inhibitors
    Han, Ying-Shan
    Xiao, Wei-Lie
    Quashie, Peter K.
    Mesplede, Thibault
    Xu, Hongtao
    Deprez, Eric
    Delelis, Olivier
    Pu, Jian-Xin
    Sun, Han-Dong
    Wainberg, Mark A.
    ANTIVIRAL RESEARCH, 2013, 98 (03) : 441 - 448
  • [27] Effect of substitution on novel tricyclic HIV-1 integrase inhibitors
    Fardis, Maria
    Jin, Haolun
    Jabri, Salman
    Cai, Ruby Z.
    Mish, Michael
    Tsiang, Manuel
    Kim, Choung U.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (15) : 4031 - 4035
  • [28] Synthesis of novel thiazolothiazepine based HIV-1 integrase inhibitors
    Aiello, F
    Brizzi, A
    Garofalo, A
    Grande, F
    Ragno, G
    Dayam, R
    Neamati, N
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (16) : 4459 - 4466
  • [29] Aib modified dimerization inhibitor of HIV-1 integrase
    Zhao, Lei
    Chmielewski, Jean
    PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 337 - 338
  • [30] The LEDGINs: first-in-class allosteric HIV-1 integrase inhibitors
    Desimmie, B.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 : 14 - 14